BKBrigitte Kasper

Brigitte Kasper

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Brigitte Kasper has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Syntaxin 11 is required for NK and CD8+ T‐cell cytotoxicity and neutrophil degranulation

    by Orietta D'ORlando, Fang Zhao, Brigitte Kasper, Zane Orinska, Jürgen Müller, Irm Hermans‐Borgmeyer, Gillian M. Griffiths, Udo Zur Stadt, Silvia Bulfone‐Paus

    Syntaxin 11 (STX11) controls vesicular trafficking and is a key player in exocytosis. Since Stx11 mutations are causally associated with a familial hemophagocytic lymphohistio‐cytosis, we wanted to clarify whether STX11 is functionally important for key immune cell populations. This was studied in primary cells obtained from newly generated Stx11−/− mice. Our data revealed that STX11 is not only widely expressed in different immune cells, but also induced upon LPS or IFN‐γ treatment. However, Stx11 deficiency does not affect macrophage phagocytic function and cytokine secretion, mast cell activation, or antigen presentation by DCs. Instead, STX11 selectively controls lymphocyte cytotoxicity in NK and activated CD8+ T cells and degranulation in neutrophils. Stx11−/− NK cells and CTLs show impaired degranulation, despite a comparable activation, maturation and expression of the complex‐forming partners MUNC18–2 and VTI1B. In addition, Stx11−/− CTLs and NK cells produce abnormal levels of IFN‐γ. Since functional reconstitution rescues the defective phenotype of Stx11−/− CTLs, we suggest a direct, specific and key role of STX11 in controlling lymphocyte cytotoxicity, cytokine production and secretion. Finally, we show that these mice are a very useful tool for dissecting the role of STX11 in vesicular trafficking and secretion.


  • FcγRIIA and FcγRIIIB Are Required for Autoantibody-Induced Tissue Damage in Experimental Human Models of Bullous Pemphigoid

    by Xinhua Yu, Karoline Holdorf, Brigitte Kasper, Detlef Zillikens, Ralf J. Ludwig, Frank Petersen


  • Open Access

    CXCL4‐induced monocyte survival, cytokine expression, and oxygen radical formation is regulated by sphingosine kinase 1

    by Brigitte Kasper, Supandi Winoto‐Morbach, Jessica Mittelstädt, Ernst Brandt, Stefan Schütze, Frank Petersen

    Human monocytes respond to a variety of stimuli with a complex spectrum of activities ranging from acute defense mechanisms to cell differentiation or cytokine release. However, the individual intracellular signaling pathways related to these functions are not well understood. CXC chemokine ligand 4 (CXCL4) represents a broad activator of monocytes, which induces acute as well as delayed activities in these cells including cell differentiation, survival, or the release of ROS, and cytokines. Here, we report for the first time that CXCL4‐treated monocytes significantly upregulate sphingosine kinase 1 (SphK1) mRNA and that CXCL4 induces SphK1 enzyme activity as well as its translocation to the cell membrane. Furthermore, we could show that pharmacological inhibition of SphK results in reversal of CXCL4‐induced monocyte survival, cytokine expression, and release of oxygen radicals, which was confirmed by the use of SphK1‐specific siRNA. CXCL4‐mediated rescue from apoptosis, which is accompanied by inhibition of caspases, is controlled by SphK1 and its downstream element Erk. Taken together, these data assign SphK1 as a central regulator of acute and delayed monocyte activation and suggest SphK1 as a potential therapeutic target to suppress pro‐inflammatory responses induced by CXCL4.


  • Expression and functionality of proteinase-activated receptors (PARs) on primary human lung mast cells

    by O Ghulam, F Petersen, B Kasper, E Brandt

    Introduction: Mast cell (MC) activation is known to promote anaphylactic reactions as well as the development of allergic and non-allergic inflammatory diseases. Apart from reacting to cross-linking of IgE-receptors by allergen, MC can be activated through a variety of alternative mechanisms. There is initial evidence that also proteinase-activated receptors (PARs) could have a role. PARs belong to the G protein-coupled receptor family and comprise four members (PAR-1 to 4). While the expression of functional PAR-2 on human skin MC as well as mRNA expression for PAR-1, PAR-3 and PAR-4 has been reported recently, so far nothing is known about the expression and the potential function(s) of PARs on primary human lung MC. We, therefore, isolated primary MC from human lung tissue and examined the expression and functionality of PARs. Methods: Human primary lung MC were isolated by a three-step procedure including enzymatic lung tissue digestion, density gradient centrifugation, and immunoaffinity purification by using anti-CD117 and anti-CD203c antibodies. Results: Using >95% pure MC we could show mRNA expression for PAR-1, PAR-2, PAR-3 and PAR-4. PAR-specific antibodies revealed the expression of PAR-1 on the cell membrane and of PAR-2 being located intracellularly, whereas PAR-3 and PAR-4 were not detected by the antibodies used. PAR-activating peptides (PAR-APs) selective for PAR-1, PAR-2 and PAR-4 were able to induce elevation of intracellular free Ca2+-ion concentration ([Ca2+]i) in these cells. Moreover, PAR-1-AP and PAR-4-AP, but not PAR-2-AP stimulated MC degranulation as determined by the release of β-hexosaminidase. Stimulation with PAR-1-selective ligands led to downregulation of PAR-1. Looking for the effect of natural PAR-ligands, we tested proteinases from blood (thrombin, factor Xa, plasmin), from leukocytes (elastase, cathepsin G, proteinase 3), trypsin, and also MC-specific proteinases (chymase, tryptase). Out of these, only thrombin (PAR-1, and -4-ligand) and trypsin (PAR-2-ligand) induced Ca2+-signalling whereas none induced degranulation. Discussion: Our results demonstrate the functional expression of PAR-1, PAR-2 and PAR-4 in primary human lung MC. However, the induction of Ca2+-signalling in the absence of a degranulation response to thrombin and trypsin suggests, that natural ligands for these receptors may act differently from synthetic APs and moreover are likely to stimulate alternative functions in human primary lung MC.

  • Familial Hemophagocytic Lymphohistiocytosis Type 5 (FHL-5) Is Caused by Mutations in Munc18-2 and Impaired Binding to Syntaxin 11

    by Udo Zur Stadt, Jan Rohr, Wenke Seifert, Florian Koch, Samantha Grieve, Julia Pagel, Julia Strauß, Brigitte Kasper, Gudrun Nürnberg, Christian Becker, et al.


  • Open Access

    Platelet Factor 4 (CXC Chemokine Ligand 4) Differentially Regulates Respiratory Burst, Survival, and Cytokine Expression of Human Monocytes by Using Distinct Signaling Pathways

    by Brigitte Kasper, Ernst Brandt, Sven Brandau, Frank Petersen

    Platelet factor 4 (PF4; CXCL4) is an abundant platelet α-granule CXC chemokine with unique functions. Although lacking a chemotactic activity, PF4 initiates a signal transduction cascade in human monocytes leading to the induction of a broad spectrum of acute and delayed functions including phagocytosis, respiratory burst, survival, and the secretion of cytokines. Surprisingly, although these monocyte functions are well defined, only very limited information exists on the specific signaling pathways that are involved in the regulation of these biological responses. By using specific inhibitors and direct phosphorylation/activation studies, we show in the present study that PF4-mediated respiratory burst is dependent on a very rapid activation of PI3K, Syk, and p38 MAPK. Moreover, monocyte survival and differentiation instead is controlled by a delayed activation of Erk, with an activity peak after 6 h of stimulation. The inhibition of Erk completely reverted PF4-mediated protection against apoptosis. Finally, even though JNK is rapidly activated in PF4-treated monocytes, it is dispensable for the regulation of survival and respiratory burst. However, PF4-induced up-regulation of chemokine and cytokine mRNA and protein requires a sustained activation of JNK and Erk. Taken together, PF4-stimulated immediate monocyte functions (oxygen radical formation) are regulated by p38 MAPK, Syk, and PI3K, whereas delayed functions (survival and cytokine expression) are controlled by Erk and JNK.


  • Neutrophil adhesion to endothelial cells induced by platelet factor 4 requires sequential activation of Ras, Syk, and JNK MAP kinases

    by Brigitte Kasper, Ernst Brandt, Martin Ernst, Frank Petersen

    Signal transduction mechanisms associated with neutrophil activation by platelet factor 4 (PF4; CXCL4) are as yet poorly characterized. In a recent report, we showed that PF4-induced neutrophil functions (such as adhesion and secondary granule exocytosis) involve the activation of Src-kinases. By analyzing intracellular signals leading to adherence, we here demonstrate by several lines of evidence that in addition to Src-kinases, PF4 signaling involves the monomeric GTPase Ras, the tyrosine kinase Syk, and the MAP kinase JNK. Furthermore, on stimulation, GTPases Rac2 and RhoA were activated, and each was translocated to a different membrane compartment. As shown by inhibitor studies, Rac2 and JNK are located downstream of Syk and Ras. Most intriguingly, the latter 2 elements appear to control the activity of Rac2 and JNK independently of each other at different phases of the activation process. Although a first phase of Rac2 and JNK activation of up to 5 minutes is initiated by Ras, the second phase (5-30 minutes) depends predominantly on the activity of Syk. In summary, we describe that coordinated activity of Syk, Ras, and JNK mediates neutrophil adhesion to endothelial cells and that PF4 induces sequential activation of these elements.


  • Top Cited Papers
    Open Access

    Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11

    by Udo Zur Stadt, Susanne Schmidt, Brigitte Kasper, Karin Beutel, A. Sarper Diler, Jan-Inge Henter, Hartmut Kabisch, Reinhard Schneppenheim, Peter Nürnberg, Gritta Janka, et al.

    Familial hemophagocytic lymphohistiocytosis (FHL) is a rare autosomal recessive disorder characterized by hyperactive phagocytes and defects in natural killer cell function. It has been shown previously that mutations in the perforin 1 gene (PRF1) and in UNC13D are associated with FHL2 and FHL3, respectively, indicating genetic heterogeneity. We performed genome-wide homozygosity mapping in a large consanguineous Kurdish kindred with five children affected with FHL. Linkage to a 10 cM region on chromosome 6q24 between D6S1569 and D6S960 defined a novel FHL locus. By screening positional candidate genes, we identified a homozygous deletion of 5 bp in the syntaxin 11 gene (STX11) in this family. We could demonstrate that syntaxin 11 protein was absent in the mononuclear cell fraction of patients with the homozygous 5 bp deletion. In addition to this family, we found homozygous mutations in STX11 in five consanguineous Turkish/Kurdish FHL kindreds including two families with the 5 bp deletion, one family with a large 19.2 kb genomic deletion spanning the entire coding region of STX11 (exon 2) and two families with a nonsense mutation that leads to a premature stop codon in the C-terminal end of the protein. As both STX11 and UNC13D are involved in vesicle trafficking and membrane fusion, we conclude that, besides mutations in perforin 1, defects in the endocytotic or the exocytotic pathway may be a common mechanism in FHL.


  • Platelet Factor 4/CXCL4 Induces Phagocytosis and the Generation of Reactive Oxygen Metabolites in Mononuclear Phagocytes Independently of Gi Protein Activation or Intracellular Calcium Transients

    by Olga Pervushina, Barbara Scheuerer, Norbert Reiling, Lars Behnke, Jens.-M SchrödEr, Brigitte Kasper, Ernst Brandt, Silvia Bulfone-Paus, Frank Petersen

    Platelet factor 4 (PF-4), a platelet-derived CXC chemokine, is known to prevent human monocytes from apoptosis and to promote differentiation of these cells into HLA-DR− macrophages. In this study, we investigated the role of PF-4 in the control of acute monocyte proinflammatory responses involved in the direct combat of microbial invaders. We show that PF-4 increases monocyte phagocytosis and provokes a strong formation of oxygen radicals but lacks a chemotactic activity in these cells. Compared with FMLP, PF-4-induced oxidative burst was later in its onset but was remarkably longer in its duration (lasting for up to 60 min). Furthermore, in PF-4-prestimulated cells, FMLP- as well as RANTES-induced burst responses became synergistically enhanced. As we could show, PF-4-mediated oxidative burst in monocytes does not involve Gi proteins, elevation of intracellular free calcium concentrations, or binding to CXCR3B, a novel PF-4 receptor recently discovered on endothelial cells. Moreover, we found that PF-4 acts on macrophages in a dual manner. On the one hand, very similar to GM-CSF or M-CSF, PF-4 treatment of monocytes generates macrophages with a high capacity for unspecific phagocytosis. On the other hand, short term priming of GM-CSF-induced human macrophages with PF-4 substantially increases their capability for particle ingestion and oxidative burst. A comparable effect was also observed in murine bone marrow-derived macrophages, indicating cross-reactivity of human PF-4 between both species. Taken together, PF-4 may play a crucial role in the induction and maintenance of an unspecific immune response.